EMN · Insider Trading
Eastman Chemical Company
Every open-market purchase and sale reported by EMN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-09 | Renee J Hornbaker | Director | A | +480 deriv. | — |
| 2026-10-09 | Damon J Audia | Director | A | +1,482 deriv. | — |
| 2026-10-09 | Humberto P Alfonso | Director | A | +1,642 deriv. | — |
| 2026-10-09 | Linnie M Haynesworth | Director | A | +480 deriv. | — |
| 2026-10-09 | Brett D Begemann | Director | A | +1,842 deriv. | — |
| 2026-10-09 | Eric L Butler | Director | A | +480 deriv. | — |
| 2026-10-09 | Julie Fasone Holder | Director | A | +480 deriv. | — |
| 2026-10-09 | Donald W Slager | Director | A | +480 deriv. | — |
| 2026-10-09 | James J /ky Obrien | Director | A | +480 deriv. | — |
| 2026-10-09 | Kim Ann Mink | Director | A | +480 deriv. | — |
| 2026-09-03 | James J /ky Obrien | Director | G | — | — |
| 2026-08-06 | Adrian James Holt | SVP, Chf HR Ofcr | Sell | −3,283 | −$234.11K |
| 2026-06-03 | Adrian James Holt | SVP, Chf HR Ofcr | MIXED | +3,283 | −$79.87K |
| 2026-05-11 | Damon J Audia | Director | A | +1,628 deriv. | — |
| 2026-05-11 | Linnie M Haynesworth | Director | A | +1,628 | — |
| 2026-05-11 | Eric L Butler | Director | A | +1,628 | — |
| 2026-05-11 | James J /ky Obrien | Director | A | +1,628 | — |
| 2026-05-11 | Renee J Hornbaker | Director | A | +1,628 | — |
| 2026-05-11 | Julie Fasone Holder | Director | A | +1,628 | — |
| 2026-05-11 | Donald W Slager | Director | A | +1,628 | — |
| 2026-05-11 | Kim Ann Mink | Director | A | +1,628 deriv. | — |
| 2026-05-11 | Brett D Begemann | Director | A | +1,628 deriv. | — |
| 2026-05-11 | Humberto P Alfonso | Director | A | +1,628 deriv. | — |
| 2026-05-07 | Adrian James Holt | SVP, Chf HR Ofcr | Sell | −1,709 | −$131.68K |
| 2026-04-10 | Kim Ann Mink | Director | A | +408 deriv. | — |
| 2026-04-10 | Renee J Hornbaker | Director | A | +408 deriv. | — |
| 2026-04-10 | Donald W Slager | Director | A | +408 deriv. | — |
| 2026-04-10 | Julie Fasone Holder | Director | A | +408 deriv. | — |
| 2026-04-10 | Humberto P Alfonso | Director | A | +1,396 deriv. | — |
| 2026-04-10 | James J /ky Obrien | Director | A | +408 deriv. | — |
| 2026-04-10 | Linnie M Haynesworth | Director | A | +408 deriv. | — |
| 2026-04-10 | Brett D Begemann | Director | A | +1,567 deriv. | — |
| 2026-04-10 | Eric L Butler | Director | A | +408 deriv. | — |
| 2026-04-10 | Damon J Audia | Director | A | +1,260 deriv. | — |
| 2026-02-26 | William Thomas McLain Jr. | EVP, CFO | A | +68,028 deriv. | — |
| 2026-02-26 | Brad A Lich | EVP & CCO | A | +71,807 deriv. | — |
| 2026-02-26 | Bosede Ikeolu Gbadegesin | SVP, CLO & Corporate Secretary | A | +37,794 deriv. | — |
| 2026-02-26 | Michelle H Caveness | SVP & Chf. Mfg. Ofc. | A | +37,794 deriv. | — |
| 2026-02-26 | Brian Travis Smith | EVP, AFP, Mfg., WWEC & HSE | A | +60,470 deriv. | — |
| 2026-02-26 | Mark J Costa | CEO & Board Chair | A | +264,552 deriv. | — |
| 2026-02-26 | Julie A. McAlindon | SVP, Regions & Chf SupChn Ofcr | A | +27,716 deriv. | — |
| 2026-02-26 | Michelle Renee Stewart | Controller & CAO | A | +12,599 deriv. | — |
| 2026-02-26 | Adrian James Holt | SVP, Chf HR Ofcr | A | +36,535 deriv. | — |
| 2026-02-20 | Stephen Glenn Crawford | EVP, Chief Tech and Sust. Ofc. | F | −4,720 | −$378.83K |
| 2026-02-20 | Mark J Costa | CEO & Board Chair | F | −25,260 | −$2.03M |
| 2026-02-20 | William Thomas McLain Jr. | EVP, CFO | F | −4,471 | −$358.84K |
| 2026-02-20 | Michelle Renee Stewart | Controller & CAO | F | −1,063 | −$85.32K |
| 2026-02-20 | Michelle H Caveness | SVP & Chf. Mfg. Ofc. | F | −528 | −$42.38K |
| 2026-02-20 | Julie A. McAlindon | SVP, Regions & Chf SupChn Ofcr | F | −1,812 | −$145.43K |
| 2026-02-20 | Brian Travis Smith | EVP, AFP, Mfg., WWEC & HSE | F | −3,086 | −$247.68K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Mark J Costa | CEO & Board Chair | 501,156 | $33.88M |
| Brad A Lich | EVP & CCO | 99,374 | $6.72M |
| Stephen Glenn Crawford | EVP, Chief Tech and Sust. Ofc. | 68,173 | $4.61M |
| William Thomas McLain Jr. | EVP, CFO | 65,313 | $4.42M |
| David W Raisbeck | Director | 29,357 | $1.98M |
| Renee J Hornbaker | Director | 25,565 | $1.73M |
| Christopher Moore Killian | SVP, CTO & Sust. Ofc, | 24,248 | $1.64M |
| Brian Travis Smith | EVP, AFP, Mfg., WWEC & HSE | 24,235 | $1.64M |
| Julie Fasone Holder | Director | 19,174 | $1.30M |
| Julie A. McAlindon | SVP, Regions & Chf SupChn Ofcr | 19,086 | $1.29M |
| Eric L Butler | Director | 10,958 | $740.87K |
| Humberto P Alfonso | Director | 9,878 | $667.85K |
| Brett D Begemann | Director | 9,520 | $643.65K |
| James J /ky Obrien | Director | 9,488 | $641.48K |
| Michelle H Caveness | SVP & Chf. Mfg. Ofc. | 7,655 | $517.55K |
| Michelle Renee Stewart | Controller & CAO | 7,315 | $494.57K |
| Donald W Slager | Director | 3,303 | $223.32K |
| Linnie M Haynesworth | Director | 3,135 | $211.96K |
| Kim Ann Mink | Director | 2,840 | $192.01K |
| Damon J Audia | Director | 1,597 | $107.97K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the EMN quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.